Last Updated on July 3, 2026 2:04 pm by BIZNAMA NEWS

Ahmedabad

Senores Pharmaceuticals Limited is proud to be Certified™ by Great Place To Work®. This prestigious Certification is based entirely on what current employees say about their experience working at Senores. This year, our employees said it’s a great place to work.

Great Place To Work is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.

“We are incredibly proud to be Great Place To Work Certified. At Senores, our people are at the heart of everything we do. We strive to foster a culture built on trust and transparency, where every individual feels valued and inspired to grow. This recognition belongs to our dedicated employees whose passion, commitment and unwavering efforts make Senores the workplace it is today,” said Managing Director, Swapnil Shah.

About Senores Pharmaceuticals Limited:

Senores Pharmaceuticals Limited is a global research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms.

The companies’ current portfolio includes 51 ANDAs and 34 CMO/CDMO commercial products that are permitted for distribution in the USA. Senores is also engaged in the development and manufacturing of complex generics certified by global food and drugs authorities and delivers generic drugs for emerging markets catering to more than 40 countries. The company currently has approval from regulatory bodies of more than 10 countries for its manufacturing facility in Chhatral for emerging markets with over 478 product registrations and over 904 product applications. Senores also manufactures critical-care injectables and Active Pharmaceutical Ingredients (APIs).

Senores has 3 manufacturing facilities for formulations – one in Atlanta, US which is USFDA approved and DEA/BAA compliant, second in Gujarat, which is also USFDA approved and the third in Chhatral, Ahmedabad, India approved by WHO-GMP to cater to Emerging Markets. The company also has 2 manufacturing facilities for API in India, both located around Ahmedabad, with one in Chhatral and the other in Naroda. Senores has strong R&D capabilities to drive differentiated product portfolio across 3 R&D sites (1 in the USA and 2 in India).

Safe Harbor Statement:

Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential project characteristics, project potential and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. The company assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.